Neuroinflammation is involved in the pathogenesis of amyotrophic lateral sclerosis (ALS),
but only limited data are available on systematic peripheral and central immune cell profiles …

MS (multiple sclerosis) and ALS (amyotrophic lateral sclerosis) differ in important respects,
but common pathogenic features seem to be shared in these two diseases. To shed light on …

Rentzos M, Evangelopoulos E, Sereti E, Zouvelou V, Marmara S, Alexakis T, Evdokimidis I.
Alterations of T cell subsets in amyotrophic lateral sclerosis: a systemic immune activation …

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease which leads
to death in a median time of 2–3 years. Inflammation has been claimed important to the ALS …

Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease with a median
lifespan of 2–3 years after diagnosis. There are few meaningful treatments that alter …

Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease characterized by
muscle weakness due to the degeneration of the upper and lower motor neurons …

Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease with poorly
understood etiology. Increasing evidence suggest that inflammation may play a critical role …

Objective: To elucidate amyotrophic lateral sclerosis (ALS) biomarkers and potential
mechanisms of disease, we measured immune cell populations in whole blood from a large …

We measured the intracellular productions of IFNγ, IL-2, IL-4, IL-13 and TNFα in peripheral
blood CD4+ and CD8+ T cells from 21 amyotrophic lateral sclerosis (ALS) patients, 14 …

Immunity has emerged as a key player in neurodegenerative diseases such as amyotrophic
lateral sclerosis, with recent studies documenting aberrant immune changes in patients and …